Skip to main content
. 2021 Aug;4(4):570–579. doi: 10.1016/j.euo.2020.12.001

Table 2.

Numbers contributed to each subtype analysis, by study

Noncancers Cancers
All Family history
Metastatic
Gleason
Aggressive
Age at diagnosis
Death
FH+ FH– U M1 M0 U >7 7 <7 U Agg. Int. Non. U <65 ≥65 U PrCa
Tier 1 status
+ve 8 65 26 27 12 8 43 14 18 14 21 12 35 11 15 4 50 14 1 21
–ve 3345 5495 2053 2557 885 496 3885 1114 1283 1350 2102 760 2202 1178 1652 463 3660 1714 121 1182
+ve Prev (%) (0.24) (1.17) (1.25) (1.04) (1.59) (1.09) (1.38) (1.03) (0.99) (1.56) (0.93) (0.90) (1.35) (0.81) (1.75)
Total 3353 5560 2079 2584 897 504 3928 1128 1301 1364 2123 772 2237 1189 1667 467 3710 1728 122 1203
Tier 2 status
+ve 135 387 153 169 65 35 272 80 81 106 153 47 143 99 120 25 265 117 5 69
–ve 3218 5173 1926 2415 832 469 3656 1048 1220 1258 1970 725 2094 1090 1547 442 3445 1611 117 1134
+ve Prev (%) (4.03) (6.96) (7.36) (6.54) (6.94) (6.92) (6.23) (7.77) (7.21) (6.39) (8.33) (7.20) (7.14) (6.77) (5.74)
Total 3353 5560 2079 2584 897 504 3928 1128 1301 1364 2123 772 2237 1189 1667 467 3710 1728 122 1203
Tier 1 + 2 status
+ve 143 448 178 193 77 43 312 93 99 120 171 58 176 109 134 29 312 130 6 88
–ve 3210 5112 1901 2391 820 461 3616 1035 1202 1244 1952 714 2061 1080 1533 438 3398 1598 116 1115
+ve Prev (%) (4.26) (8.06) (8.56) (7.47) (8.53) (7.94) (7.61) (8.80) (8.05) (7.87) (9.17) (8.04) (8.41) (7.52) (7.32)
Total 3353 5560 2079 2584 897 504 3928 1128 1301 1364 2123 772 2237 1189 1667 467 3710 1728 122 1203

Agg. = aggressive; FH = family history; Int. = intermediate aggressive; Non. = nonaggressive; PrCa = prostate cancer; Prev = prevalence; U = unknown.